Cargando…

Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis

Background and aims: The aims of our study were to elucidate the relationship between baseline characteristics of hepatocellular carcinoma (HCC) patients complicating with liver cirrhosis (LC) and performance status (PS) and to investigate the impact of PS on survival in patients with HCC complicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishikawa, Hiroki, Kita, Ryuichi, Kimura, Toru, Ohara, Yoshiaki, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Osaki, Yukio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349881/ https://www.ncbi.nlm.nih.gov/pubmed/25767611 http://dx.doi.org/10.7150/jca.11212

Ejemplares similares

Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
por: Takeda, Haruhiko, et al.
Publicado: (2019)

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
por: NISHIKAWA, HIROKI, et al.
Publicado: (2012)

Cold snare polypectomy reduced delayed postpolypectomy bleeding compared with conventional hot polypectomy: a propensity score-matching analysis
por: Yamashina, Takeshi, et al.
Publicado: (2017)

Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter
por: Yamashina, Takeshi, et al.
Publicado: (2018)

Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy
por: NISHIKAWA, HIROKI, et al.
Publicado: (2013)

Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus
por: Nishijima, Norihiro, et al.
Publicado: (2018)

Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2011)

Treatment for Hepatocellular Carcinoma in Elderly Patients: A Literature Review
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin
por: Nishikawa, Hiroki, et al.
Publicado: (2010)

Comparison of Clinical Characteristics and Survival after Surgery in Patients with Non-B and Non-C Hepatocellular Carcinoma and Hepatitis Virus-Related Hepatocellular Carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases
por: Takeda, Haruhiko, et al.
Publicado: (2012)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review
por: Osaki, Yukio, et al.
Publicado: (2015)

Genetic Heterogeneity of Hepatitis C Virus in Association with Antiviral Therapy Determined by Ultra-Deep Sequencing
por: Nasu, Akihiro, et al.
Publicado: (2011)

Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing
por: Nishijima, Norihiro, et al.
Publicado: (2012)

Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib
por: Sakai, Kazuko, et al.
Publicado: (2015)

Clinical Significance of Occult Hepatitis B Infection in Progression of Liver Disease and Carcinogenesis
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Usefulness of autotaxin for the complications of liver cirrhosis
por: Shao, Xue, et al.
Publicado: (2020)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Proton Beam Therapy for Hepatocellular Carcinoma Patients with Severe Cirrhosis
por: Hata, Masaharu, et al.
Publicado: (2006)

EP4 Receptor–Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis
por: Nakatsuji, Masato, et al.
Publicado: (2015)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing
por: Takeda, Haruhiko, et al.
Publicado: (2017)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2017)

Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs
por: Nishikawa, Koji, et al.
Publicado: (2018)

Transition in the etiology of liver cirrhosis in Japan: a nationwide survey
por: Enomoto, Hirayuki, et al.
Publicado: (2019)

Concurrent Activation of Acetylation and Tri-Methylation of H3K27 in a Subset of Hepatocellular Carcinoma with Aggressive Behavior
por: Hayashi, Akimasa, et al.
Publicado: (2014)

Surgery to avoid fatal complications and secure radicality after definitive chemoradiotherapy for clinical T4N2M0 stage IIIB non-small cell lung cancer: a case report
por: Yagi, Yuriko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0evfvq836oce6vfiijreqf9d1u